{"id":16683,"date":"2013-06-01T10:30:00","date_gmt":"2013-06-01T08:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/menarini-solidarieta-per-1-700-informatori\/"},"modified":"2013-06-01T10:30:00","modified_gmt":"2013-06-01T08:30:00","slug":"menarini-solidarieta-per-1-700-informatori","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/menarini-solidarieta-per-1-700-informatori\/","title":{"rendered":"Menarini: solidarity for 1,700 informers"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 12pt\">The Menarini group, grappling with the difficulties of the national market and the effects of the law in favor of generic drugs, is thinking of a pay cut in the order of 40-45% for the 1,700 scientific representatives, as an alternative to the 730 redundancies announced (reduced compared to the initial thousand). <\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 12pt\">The proposal of the Florentine company, leader in Italy in the pharmaceutical sector, 3 billion in revenues and 12,000 employees, was formalized yesterday in Rome in a meeting with trade union organizations at the Ministry of Economic Development. \u00abWe took into account the situation of the country and the problems <span style=\"mso-spacerun: yes\">&nbsp;<\/span>personal and family members of our scientific representatives, many of whom have been working with the group for years\u00bb, comments the general manager of the company, Domenico Simone. \u201cNow the union negotiation phase has begun, to verify the feasibility of this road \u2013 he adds -. But it is clear that, under current conditions, there would still be a need to restructure the workforce in a consistent manner in Italy\u00bb. <\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 12pt\">The instrument of the solidarity contract concerns four companies: Guidotti, Malesci and Lusofarmaco, in addition to the parent company Menarini. And it doesn&#039;t touch the productive part. \u201cWe have an investment plan for Italy which is blocked and which allocates 60 million to doubling the L&#039;Aquila plant \u2013 explains Simone -. But to restart it, some important obstacles to the growth of the pharmaceutical industry must be removed, restoring parity between branded and generic drugs on the market&quot;. <\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><b><i style=\"mso-bidi-font-style: normal\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #1a1a1a; font-size: 10pt\">C.Per.<\/span><\/i><\/b><span class=\"time-stamp1\"><i style=\"mso-bidi-font-style: normal\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #1a1a1a; font-size: 10pt\"> 01 June 2013<\/span><\/i><\/span><i style=\"mso-bidi-font-style: normal\"><span style=\"line-height: 115%; font-size: 10pt\"><\/p>\n<p><\/span><\/i><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\" face=\"Calibri\">C.Per. \u2013 Il Sole 24 Ore \u2013 read on <\/font><a href=\"http:\/\/24o.it\/oxmQXn\" target=\"_blank\" rel=\"noopener\"><font color=\"#0000ff\" size=\"3\" face=\"Calibri\">http:\/\/24o.it\/oxmQXn<\/font><\/a><font size=\"3\"><font face=\"Calibri\"> <\/p>\n<p><\/font><\/font><\/p>\n<p><img","protected":false},"excerpt":{"rendered":"<p>Il gruppo Menarini, alle prese con le difficolt&agrave; del mercato nazionale e gli effetti della legge in favore dei farmaci generici, pensa a un taglio della retribuzione nell&#8217;ordine del 40-45% per i 1.700 informatori scientifici, come alternativa ai 730 esuberi annunciati (ridotti rispetto ai mille iniziali). La proposta dell&#8217;azienda fiorentina, leader in Italia nel settore &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-16683","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=16683"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16683\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=16683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=16683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=16683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}